Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Accumulated Expenses (2020 - 2021)

Historic Accumulated Expenses for Design Therapeutics (DSGN) over the last 2 years, with Q2 2021 value amounting to $1.8 million.

  • Design Therapeutics' Accumulated Expenses changed N/A to $1.8 million in Q2 2021 from the same period last year, while for Jun 2021 it was $1.8 million, marking a year-over-year change of. This contributed to the annual value of $931000.0 for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q2 2021, Design Therapeutics' Accumulated Expenses is $1.8 million.
  • Over the past 5 years, Design Therapeutics' Accumulated Expenses peaked at $1.8 million during Q2 2021, and registered a low of $931000.0 during Q4 2020.